[1]
“The impact of Taq1A ANKK1/DRD2 Polymorphism on Dopamine in Individuals with Amphetamine Use Disorder in Basra, Iraq”, Genetics and Mol. Res., vol. 24, no. 4, pp. 1–12, Dec. 2025, doi: 10.4238/c4y77n43.